Skip to main content
Caplight Logo









Antarka

Antarka

Private
MontevideoHealthcare & Life Scienceshttps://antarka.com/

Last Round

Seed

Mar 4, 2026

Total Funding Raised

$3.95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Antarka is a biotechnology company that develops patented, Antarctic-derived enzymes for advanced skin repair and longevity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

cosmetic active ingredientDNA repairB2B ingredientbiotechnologyphotoagingcellular repaircosmeceutical ingredientextremophile enzymeUV damage repairbioactive ingredientdermocosmeticsanti-aging ingredientscience-backed skincareAntarctic biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antarka Comparables

Compare Antarka with similar companies based on industry and business-model similarity.

Antarka comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Croda International
72%
Vytrus Biotech S.A.
71%
bitop AG
71%

Antarka Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 4, 2026
AcceleratorOct 14, 2025

Key People

Founding team and executive leadership

Célica Cagide

Co-Founder & COO, Co-founder & COO

Founding Team

Stefano Valdesolo

Co-Founder & CEO

Founding Team

Antarka Investors

Notable investors and investment history

Antarka investors
InvestorRounds
Zentynel Frontier InvestmentsSeed
GS FuturesSeed
GRIDXAccelerator
AIR CapitalSeed
Agencia Nacional de Investigación e InnovaciónGrant
SOSVSeed, Accelerator
Vox CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    $4M round led by Natura Ventures and Zentynel Frontier Investments.

  • Oct 14, 2025

    $250K round led by SOSV

Antarka Filings

Explore SEC and related filing metadata, where available.

Antarka filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Antarka's valuation, stock price, and market status.

Is Antarka a public or private company?

Antarka is a private company.

What is the current stock price of Antarka?

Antarka is a private company with no public stock price. No recent secondary market data is available.

How much is Antarka worth (valuation)?

Valuation information for Antarka is not publicly available.

Can I buy Antarka stock?

Antarka shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Antarka's last funding round?

Antarka's most recent funding round was Seed on March 4, 2026.

Who are the main investors in Antarka?

Key investors in Antarka include Zentynel Frontier Investments, VOX Capital.

Will Antarka IPO soon?

No public IPO plans have been announced for Antarka.

How can I track Antarka secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antarka's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range7
Year Founded2023
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?